New Directions In STD Treatment - University of Hawaii

More documents

Recommendations

Info

Sexual History Taking: The 5 P’s 4. Practices � To understand your risks for STDs, I need to understand the kind of sex you have had recently. � Have you had vaginal sex, meaning penis in the vagina sex? If yes, do you use condoms never, sometimes or always? � Have you had anal sex, meaning penis in the rectum/anus/butt sex? If yes, do you use condoms never, sometimes or always? � Have you had oral sex, meaning mouth on penis/vagina/rectum sex? If yes, do you use condoms never, sometimes or always? � For condoms: if never: Why don’t you use condoms? If sometimes: In what situations or with whom do you use or not use condoms? 5. Past History of STDs � Have you ever Had an STD? � Have any of your partners had an STD? � Additional questions to identify HIV and Hepatitis risk � Have you or any of your partners ever injected drugs � Have you or any of your partners exchanged money or drugs for sex � Is there anything else about your sexual practices that I need to know about?
Recommend Nucleic Acid Amplification Tests for Detecting Chlamydia and � Highest sensitivity � Noninvasive Gonorrhea � Able to detect up to 40% more CT infections � Less dependent on specimen collection and handling � Urine and self-collected vaginal swabs � Non-clinical settings � Pelvic and genital exams not necessary � Clinic intake areas � Community based organizations � Home testing
Page 1 and 2: New Directions in STD Treatment: Hi
Page 3 and 4: CDC 2006 STD Treatment Guidelines D
Page 5 and 6: Challenging Management Dilemmas in
Page 7: Sexual History Taking: The 5 P’s
Page 11 and 12: Percent Screened Estimated Chlamydi
Page 13 and 14: STD Screening for MSM STD Site Type
Page 15 and 16: Prevalence of rectal chlamydia and
Page 17 and 18: Prevalence of pharyngeal chlamydia
Page 19 and 20: C. trachomatis NAAT Testing …not
Page 21 and 22: Chlamydia Treatment in Pregnancy Re
Page 23 and 24: Percent 16 14 12 10 Infection Durin
Page 25 and 26: Provider Barriers to PDPT, CA 2002
Page 27 and 28: Gonorrhea Screening in Females �
Page 29 and 30: Percent of Neisseria gonorrhoeae Is
Page 31 and 32: Gonorrhea Treatment of Urogenital I
Page 33 and 34: Lymphogranuloma Venereum (LGV) C. t
Page 35 and 36: LGV Proctocolitis: Serologic Diagno
Page 37 and 38: Phil and the Penis on the Go
Page 39 and 40: The Three “R”s of Syphilis �
Page 41 and 42: Latent Syphilis � No clinical man
Page 43 and 44: Syphilis EIA Tests �Treponemal te
Page 45 and 46: Criteria for CSF Examination � Ne
Page 47 and 48: Syphilis Resistant to Azithromycin!
Page 51 and 52: HSV Issues � Role of type-specifi
Page 53 and 54: Rates of Transmission of HSV-2 to S
Page 55 and 56: Genital Herpes - Treatment Issues
Page 57 and 58: HPV Issues � Clarify uses of HPV
Page 59 and 60:
Issues Regarding Anal Cancer Screen
Page 61 and 62:
Cervicitis - Diagnostic Issues �
Page 63 and 64:
Pelvic Inflammatory Disease Issues
Page 65 and 66:
PID: Oral Treatment Regimens Oral r
Page 67 and 68:
Vaginitis Trichomonas Bacterial Vag
Page 69 and 70:
Tinidazole: A New Treatment Option
Page 71 and 72:
Proposed Management Trichomoniasis
Page 73 and 74:
BV Treatment Recommended regimens:
Page 75:
STD Resources California STD/HIV Pr
show all

New Directions In STD Treatment - University of Hawaii

Create successful ePaper yourself

Delete template?

Save as template?